Rapidly progressive cognitive decline and drug-induced encephalopathy secondary to teprotumumab for thyroid eye disease: a case report and narrative literature review.
Journal: Frontiers in immunology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Cheng ZJ, Zhou SX, He ZY, et al. (2026). "Rapidly progressive cognitive decline and drug-induced encephalopathy secondary to teprotumumab for thyroid eye disease: a case report and narrative literature review.". Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1985279